期刊文献+

不同透析膜对维持性血液透析患者对外周血转化生长因子β1及单核细胞趋化蛋白-1水平的影响 被引量:2

Effects of dialyzed membrane on TGFβ1 and MCP-1 plasma levers in maintenance hemodialysis patients
下载PDF
导出
摘要 目的 研究不同透析膜对维持性血液透析 (MHD)患者外周血转化生长因子 (TGFβ1)及单核细胞趋化蛋白 -1(MCP -1)水平的影响。方法 应用酶联免疫法 (ELISA)测定长期用铜仿膜 (CU )和聚砜膜 (PSU )透析患者外周血TGFβ1及MCP -1水平。 结果 与正常对照组相比 ,CU和PSU透析患者外周血TGFβ1水平明显增加 (P <0 .0 1,P <0 .0 5 ) ,但PSU与CU透析组相比 ,外周血TGFβ1水平明显下降 (P <0 .0 5 ) ;MHD患者外周血MCP -1水平也有所增加 ,其中PSU透析组与对照组相比有统计学意义 (P <0 .0 5 )。另外 ,CU与PSU透析组内TGFβ1与MCP -1水平之间均呈明显负相关 (r =-0 .5 42 5与 -0 .45 62 ,P <0 .0 5 )。结论 尿毒症患者MHD可增加外周血TGFβ1与MCP -1水平 。 Objective To investigate effects of different dialyzed membrane on plasma TGFβ1 and MCP-1 levers in maintenance hemodialysis (MHD) patients.Methods The plasma concentrations of TGFβ1 and MCP-1 were measured by ELISA assay in well-matched uremic patients undergoing MHD with either cuprophane(CU, n =27) or polysulfone (PSU, n =25).Results Compared with controls, the patients in CU and PSU membranes dialysis had significantly increasel TGFβ1 concentration ( P <0.01, P <0.05). However,the patients in PSU membrane dialysis had significantly decreasee TGFβ1 concentrations comparel with the petients in CU membrane dialysis.MCP-1 plasma levers were also higher in patients dialyzed with CU or PSU than those in controls.In addition,negative correlation was observed between the plasma levers of TGFβ1 and MCP-1 in patients dialyzed with CU or PSU.Conclusion Our results show that MHD is associated with the increased of the plasma TGFβ1 and MCP-1 levels.Moreover,the type of dialysis membrane has different effect on the the plasma TGFβ1 and MCP-1.
出处 《安徽医学》 2003年第2期13-16,共4页 Anhui Medical Journal
关键词 透析膜 维持性血液透析 外周血转化生长因子 单核细胞趋化蛋白—1 酶联免疫法 铜仿膜 聚砜膜 Maintenance dialysis Dialyzed membrane Transforming growth factor β1 Monocyte chemoattactant protein-1
  • 相关文献

参考文献9

  • 1Massague J.Transforming growth factor-β family.Annu Rev,1990; 6:597~ 640
  • 2Anderson J,Briefel G,Jones JM,et al.Effect of acetate dialysate on transforming growth factor-β1,interleukin,and β2-microglobulin plasma levers.Kindey Int,1991; 40:1100~1117
  • 3Jiang X,Kanai H,Shigehara T,et al.Metabolism of transforming growth factor-β in patients receiving hemodialysis especially those with renal osreodystrophy.Renal Failure,1998;20:135~ 145
  • 4Rovin BH,Doe N,Tan LC.Monocyte chemoattactant protein-levers in patients with glomerular disease.Am J Kid Dis,1996; 27:640~ 646
  • 5Chantry D,Turner M,Abrey E,et al.Modulation of cytokine production transforming growth factor β.J Immumol,1989;142:4295 ~ 4300
  • 6Shull MM,Ormsby I,Kier AB,et al.Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease.Nature,1992; 359:692~ 699
  • 7Mege JL,Capo C,Purgus R,et al.Monocyte production of transforming growth factor β in long-term hemodialysis:Modulation by hemodialysis membranes.Am J Kid Dis,1996;28:395 ~ 399
  • 8Schindler R,Lonnemann G,Shaldon S,et al.Transcription not syntresis of interleukin 1 and tumor necrosis factor by complement.Kidney Int,1990; 37; 85 ~ 93
  • 9Welch GR,Wong HL,Wahl SM,et al.Selective induction of fγcRⅢ on human monocytes by transforming growth factor β.J Immunol,1900; 144:3444~ 3448

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部